NeoMedLight develops innovative medical devices designed for phototherapy. The company is the owner of a unique and proprietary technology: the emission of light through woven optic fibers.
NeoMedLight was created as a spin-off of Brochier Technologies, to focus on the development of medical applications leveraging our patented flexible luminous fabric.
NeoMedLight launched its phototherapy device for the treatment of neonatal jaundice. It’s called Bilicocoon. Bilicocoon is commercialised in 30 countries.
NeoMedLight is expecting to launch CareMin650™ in the first half of 2020.
Cédric Brochier, is Co-founder and President of NeoMedLight® with a special focus on R&D. Through his family history in silk and technical weaving, he comes with a strong expertise to develop fabrics made of optic fibers.
He is the inventor of the patent around which NeoMedLight® has been created. He is also the president and CEO of Brochier Technologies and Brochier Soieries.
Pierre Saint Girons
Pierre Saint Girons is Cofounder & CEO of NeoMedLight®. He comes with over 20 years of international experience in the medical device industry.
He served in various senior positions mostly for large size companies. He also sits on the board of startups and is an active member of an investment committee dedicated to investments in the healthcare sector.
An unrivalled medical device for severe cancer treatment complications: exact & easy red-LED photobiomodulation for Mucositis and dermatitis.
The technologies developed by our team are enabling patients to receive a quality treatment in a novel way.